Sökning: onr:"swepub:oai:DiVA.org:uu-281478" >
Association Between...
-
Hasvold, PalAstraZeneca, S-15185 Sodertalje, Sweden.;Univ Oslo, Fac Med, N-0424 Oslo, Norway.
(författare)
Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting
- Artikel/kapitelEngelska2016
Förlag, utgivningsår, omfång ...
-
2015-12-30
-
Springer Science and Business Media LLC,2016
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-281478
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-281478URI
-
https://doi.org/10.1007/s40261-015-0372-9DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:132992218URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background and Objectives Statin-induced changes in high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) are unrelated. Many patients initiated on statins experience a paradoxical decrease in HDL-C. The aim of this study was to evaluate the association between a decrease in HDL-C and risk of major adverse cardiovascular events (MACE). Methods Data from 15,357 primary care patients initiated on statins during 2004-2009 were linked with data from mandatory national hospital, drug-dispensing, and cause-of-death registers, and were grouped according to HDL-C change: decreased >= 0.1 mmol/L, unchanged +/- 0.1 or >= 0.1 mmol/L increased. To evaluate the association between decrease in HDL-C and risk of MACE, a sample of propensity score-matched patients from the decreased and unchanged groups was created, using the latter group as reference. MACE was defined as myocardial infarction, unstable angina pectoris, ischaemic stroke, or cardiovascular mortality. Cox proportional hazards models were used to estimate relative risks. Results HDL-C decreased in 20 %, was unchanged in 58%, and increased in 22 % of patients initiated on statin treatment (96 % treated with simvastatin). The propensity score-matched sample comprised 5950 patients with mean baseline HDL-C and LDL-C of 1.69 and 4.53 mmol/L, respectively. HDL-C decrease was associated with 56 % higher MACE risk (hazard ratio 1.56; 95 % confidence interval 1.12-2.16; p < 0.01) compared with the unchanged HDL-C group. Conclusions Paradoxical statin-induced reduction in HDL-C was relatively common and was associated with increased risk of MACE.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Thuresson, MarcusStatisticon AB, S-75322 Uppsala, Sweden.
(författare)
-
Sundstrom, JohanUppsala universitet,Uppsala kliniska forskningscentrum (UCR),Institutionen för medicinska vetenskaper(Swepub:uu)johasund
(författare)
-
Hammar, NiklasKarolinska Institutet
(författare)
-
Kjeldsen, Sverre E.Univ Oslo, Fac Med, N-0424 Oslo, Norway.;Oslo Univ Hosp, Dept Cardiol, Oslo, Norway.
(författare)
-
Johansson, GunnarUppsala universitet,Allmänmedicin och preventivmedicin(Swepub:uu)gunnarjs
(författare)
-
Holme, IngarNorwegian Sch Sport Sci, Dept Sports Med, POB 4014, N-0806 Oslo, Norway.
(författare)
-
Bodegard, JohanAstraZeneca, S-15185 Sodertalje, Sweden.
(författare)
-
AstraZeneca, S-15185 Sodertalje, Sweden.;Univ Oslo, Fac Med, N-0424 Oslo, Norway.Statisticon AB, S-75322 Uppsala, Sweden.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Clinical drug investigation: Springer Science and Business Media LLC36:3, s. 225-2331173-25631179-1918
Internetlänk
Hitta via bibliotek
Till lärosätets databas